8-K
filed May 26, 2026, 7:15 AM ET
ticker PASG
CIK 0001787297
other
confidence high
sentiment neutral
materiality 0.15
Passage Bio stockholders elect two Class III directors, ratify KPMG, approve say-on-pay
Passage BIO, Inc.
- Athena Countouriotis and Sandip Kapadia elected as Class III directors for three-year terms.
- KPMG LLP ratified as independent auditor for FY2026 (2,083,031 for, 41,539 against).
- Non-binding advisory vote on executive compensation approved (1,452,505 for, 36,352 against).
- Stockholders favored holding say-on-pay vote every year; board adopts annual frequency policy.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Passage BIO, Inc. shareholders approved Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement for the Annual Meeting at the 2026-05-19 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-05-19
Exact text from the filing
Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement for the Annual Meeting: Shares For Shares Against Shares Abstaining Broker Non-Votes 1,452,505 36,352 1,356 637,397
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Passage BIO, Inc. shareholders approved Election of two Class III directors at the 2026-05-19 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-19
Exact text from the filing
Election of two Class III directors, identified in the table below, each to serve a three-year term, which will expire at the 2029 Annual Meeting of Stockholders and until such time as their respective successors have been duly elected and qualified or until their earlier resignation or removal: Nominees Shares For Shares Withheld Broker Non-Votes Athena Countouriotis, M.D. 971,120 519,093 637,397 Sandip Kapadia 972,608 517,605 637,397
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Passage BIO, Inc. shareholders approved Approval, on a non-binding advisory basis, of the frequency of holding future advisory votes on named executive officer compensation at the 2026-05-19 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2026-05-19
Exact text from the filing
Approval, on a non-binding advisory basis, of the frequency of holding future advisory votes on named executive officer compensation: Shares for One Year Shares for Two Years Shares for Three Years Shares Abstaining Broker Non-Votes 1,450,605 5,046 28,143 6,419 637,397
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Passage BIO, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-19 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-19
Exact text from the filing
Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026: Shares For Shares Against Shares Abstaining Broker Non-Votes 2,083,031 41,539 3,040 —
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.